Affimed to Present at the Jefferies 2017 Global Healthcare Conference - New York
May 30 2017 - 5:00AM
Heidelberg, Germany, May 30, 2017 - Affimed N.V.
(Nasdaq: AFMD), a clinical stage biopharmaceutical company focused
on discovering and developing highly targeted cancer
immunotherapies, announced today that Dr. Adi Hoess, CEO, will
present at the Jefferies 2017 Global Healthcare Conference on
Tuesday, June 6, 2017 at 2:00 p.m. (ET) in New York.
A live webcast of the conference presentation
can be accessed through the "Events" section on the "Investors
& Media" page of the Affimed website at
http://www.affimed.com/events.php. A replay of the presentation
will be available from Affimed's website for 30 days following the
conference.
About Affimed N.V.
Affimed (Nasdaq: AFMD) engineers targeted
immunotherapies, seeking to cure patients by harnessing the power
of innate and adaptive immunity (NK- and T-cells). We are
developing single and combination therapies to treat cancers and
other life-threatening diseases. For more information, please visit
www.affimed.com.
IR Contact:
Caroline Stewart, Head IR Phone: +1 347394 6793 E-Mail:
IR@affimed.com or c.stewart@affimed.com
Media Contact:
Anca Alexandru, Head of Communications, EU IR Phone: +49 6221
64793341 E-Mail: a.alexandru@affimed.com
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Sep 2023 to Sep 2024